![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by Elroy on May 14, 2005, at 22:02:07
Anyone familiar with this study?
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Psychoneuroendocrinology. 2004 Oct;29(9):1101-8.
Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E
A concatenation of data indicates that the pathogenesis of depression is related to an increased production and secretion of corticotropin-releasing hormone (CRH). Benzodiazepines profoundly suppress the basal and stress-related activation of the hypothalamic-pituitary-adrenocortical (HPA) system and discontinuation of these drugs results in rebound activation. We therefore investigated whether the extent of HPA system dysregulation is related to the severity of benzodiazepine withdrawal in patients with depression. We performed the combined dexamethasone/CRH test before benzodiazepine discontinuation (taper-off max. 5 mg diazepam-equivalents/week) in 14 depressed patients (13 f, 1 m, mean age 54.6 +/- 14.6) who responded to the antidepressant treatment. The severity of withdrawal symptoms was measured using the Clinical Institute Withdrawal Assessment-Benzodiazepines (CIWA-B) questionnaire. The depressive psychopathology was monitored using the Hamilton Depression Rating Scale, Montgomery Asberg Depression Rating Scale and Beck Depression Inventory. Patients with more severe benzodiazepine withdrawal (CIWA-B-increase > 14 pts; n = 7) showed a significant higher cortisol and ACTH response in the dexamethasone/CRH test preceding the discontinuation of benzodiazepines than patients displaying less severe withdrawal symptoms (CIWA-B-increase <14 pts.; n = 7) (ANCOVA, p < 0.05). Both groups did not differ in the pre-taper psychopathology ratings and their basal neuroendocrine activity. In view of the GABAergic inhibition of HPA system activity and the anxiogenic effect of CRH, benzodiazepine withdrawal symptoms may be partly due to a disinhibition of the HPA system during discontinuation of benzodiazepines.
Posted by ed_uk on May 15, 2005, at 8:15:12
In reply to Xanax Withdrawal Problems HPA Axis?, posted by Elroy on May 14, 2005, at 22:02:07
>.........benzodiazepine withdrawal symptoms may be partly due to a disinhibition of the HPA system during discontinuation of benzodiazepines..........
Perhaps these findings could be relevent to the treatment of benzo withdrawal symptoms in patients who are finding it difficult to withdraw.
Ed.
Posted by Elroy on May 15, 2005, at 20:23:58
In reply to Re: Xanax Withdrawal Problems HPA Axis? » Elroy, posted by ed_uk on May 15, 2005, at 8:15:12
Exactly.
Would definitely suggest that one in thisposition get cortisol levels checked via a 24-hr urinary free cortisol test. Consistent high levels of cortisol could indicate a broken down HPA Axis (which also could be very responsible for the anxiety and / or depression problem).
> >.........benzodiazepine withdrawal symptoms may be partly due to a disinhibition of the HPA system during discontinuation of benzodiazepines..........
>
> Perhaps these findings could be relevent to the treatment of benzo withdrawal symptoms in patients who are finding it difficult to withdraw.
>
> Ed.
>
>
This is the end of the thread.
Psycho-Babble Withdrawal | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.